Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Combined corticosteroid and long‐acting beta‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD003794.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Luis Javier Nannini

    Correspondencia a: Pulmonary Section, Hospital E Peron, G. Baigorria, Argentina

    [email protected]

  • Christopher J Cates

    Community Health Sciences, St George's, University of London, London, UK

  • Toby J Lasserson

    Cochrane Airways Group, Divison of Community Health Sciences, St George's University of London, London, UK

  • Phillippa Poole

    University of Auckland, Auckland, New Zealand

Contributions of authors

LN and PP developed the protocol. Studies were assessed by LN and TJL. TJL and LN checked data and entered into RevMan. TJL and LN conducted the analysis. TJL and LN developed the discussion with input from PP. CJC participated in the 2004 and 2007 updates of the review and offered statistical advice and input with calculating SEMs and SDs for the included studies where appropriate.

Sources of support

Internal sources

  • Hamamellis Trust, UK.

  • NHS Cochrane Grant scheme, UK.

External sources

  • No sources of support supplied

Declarations of interest

The authors who have been involved in this review have done so without any known conflicts of interest. None of the authors is considered a paid consultant by any pharmaceutical company which produces agents discussed in this review.

Acknowledgements

The authors are indebted to the Hamamellis Trust who very generously funded the return travel for Dr Nannini to London in order to spend a week working on the development of the review. Thanks to Liz Arnold, Susan Hansen and Veronica Stewart for advice and support in developing our literature searching strategy and for retrieval of full text papers. We would also like to acknowledge the efforts of Inge Vestbo, Diane Grimley and Karen Richardson of GSK who helped us in our attempts to obtain unpublished information on the TRISTAN and Wouters 2005 studies, and those of Goran Tornling, Moira Coughlan and Roger Metcalf of AstraZeneca in helping us obtain data for Szafranski 2003. We thank Dr Nick Hanania and Prof Donald Mahler for corresponding with us in our attempts to obtain unpublished data from their studies, and Dr Dal Negro (Dal Negro 2003) for confirming the SDs in his study. We are grateful to Nancy Santesso for preparing the summary of findings table for our review.

Version history

Published

Title

Stage

Authors

Version

2013 Nov 10

Combined corticosteroid and long‐acting beta<sub>2</sub>‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Review

Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes, Rebecca Normansell

https://doi.org/10.1002/14651858.CD003794.pub4

2007 Oct 17

Combined corticosteroid and long‐acting beta‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Review

Luis Javier Nannini, Christopher J Cates, Toby J Lasserson, Phillippa Poole

https://doi.org/10.1002/14651858.CD003794.pub3

2004 Jul 19

Combined corticosteroid and longacting beta‐agonist in one inhaler for chronic obstructive pulmonary disease

Review

Luis Javier Nannini, Christopher J Cates, Toby J Lasserson, Phillippa Poole

https://doi.org/10.1002/14651858.CD003794.pub2

2003 Jul 21

Combined corticosteroid and longacting beta‐agonist in one inhaler for chronic obstructive pulmonary disease

Review

Luis Javier Nannini, Toby J. Lasserson, Phillippa Poole

https://doi.org/10.1002/14651858.CD003794

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.